Schizophrenia/Psychosis

This form of nonsuicidal self-injury occurs within a spectrum of severity, and it is very likely that cases are both underreported and unpublished.

Despite the vast research conducted to better understand biological mechanisms underlying psychosis, people with psychotic disorders continue to suffer.

Those of us who have a diagnosis of a psychotic disorder are, above all, human beings. We are more than the disorder.

Psychotic disorders are potentially serious and enduring and have been seriously neglected in health systems worldwide. The good news is that better medium-term outcomes are now achievable.

Drs Zuardi and Crippa discuss the current stage of scientific evidence that supports the use of cannabidiol in schizophrenia, anxiety, and Parkinson disease. 

As we move forward from COVID-19, we take a look at noteworthy achievements that took place at lightning speed to inform response measures in future pandemics.

Familiarity with self-disorders is an indispensable tool in diagnosing a patient suspected for developing schizophrenia. Such knowledge improves communication with the patient and may serve as a starting point for therapeutic intervention.

Psychomotor speed may be a relevant target in studies of the immune system and its impact on the brain in patients with schizophrenia.

There is inadequate information regarding optimal antipsychotic doses in the treatment of acute schizophrenia that balance efficacy and safety. This article helps you get it right.

Policy initiatives can improve both physical and mental health care quality and outcomes for those with serious mental illnesses.

Artificial intelligence combined with electronic health records may detect FEP a year before onset in asymptomatic adults.

The mortality rate is unacceptably high in patient with serious mental illnesses. Several psychosocial interventions have been developed that may benefit these patients.

New (and not-so-new) insights on antipsychotics across a range of different measures of treatment response.

Schizophrenia and bipolar disorder are among the most serious psychiatric disorders and play a disproportionate role among individuals who end up homeless, incarcerated, and who die by suicide. Why the lack of research?

Parkinson disease psychosis is associated with worsening quality of life, greater caregiver distress, higher rates of institutionalization, increased mortality, and greater health care costs. The authors explore medical, psychosocial, and psychological factors associated with PD psychosis.

All current FDA-approved medications for the treatment of schizophrenia antagonize dopamine type 2 receptors-but that is where their similarity ends.

A number of factors affect treatment adherence, including the therapeutic alliance, perceived perceived lack of control, risk of dependence on medications, stigma associated with medication use, and more.

What are the benefits of using LAI antipsychotics? What are the major obstacles to adherence? Those questions and more in this podcast.

Patients with difficult conditions such as delusional parasitosis tend to resist the notion that a psychiatric problem underlies their symptoms.

Recently, the use of spectral-domain optical coherence tomography has contributed to our understanding of retinal abnormalities in schizophrenia.

Information on minimum and maximum effective doses has great clinical utility, and new findings provide guidance.

Pseudopatients and their discontents: an historical perspective.

I would not want to simply map the stars; I would also want to gaze upon them and contemplate the mystery of it all. Such is the 15-minute med check versus the essence of psychiatry.

"The idea of seeing a patient, not just a diagnostic label, is an extremely valuable lesson. Being primed to see certain behaviors as pathological in certain contexts and perfectly normal in others is something that all doctors should be aware of." -Susannah Cahalan

Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.